| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
and Retinoid X Receptor
in Human Keratinocytes1
Department of Dermatology, University of Michigan, Ann Arbor, Michigan 48109
Repeated exposure of human skin to solar UV radiation leads to premature
aging (photoaging) and skin cancer. UV-induced skin damage can be
ameliorated by all-trans retinoic acid treatment. The
actions of retinoic acid in skin keratinocytes are mediated primarily
by nuclear retinoic acid receptor
(RAR
) and retinoid X receptor
(RXR
). We found that exposure of cultured primary human
keratinocytes to UV irradiation (30 mJ/cm2) substantially
reduced (5090%) RAR
and RXR
mRNA and protein within 8 h.
The rates of disappearance of RAR
and RXR
proteins after UV
exposure or treatment with the protein synthesis inhibitor
cycloheximide were similar. UV irradiation did not increase the rate of
breakdown of RAR
or RXR
but rather reduced their rate of
synthesis. The addition of proteasome inhibitors MG132 and LLvL, but
not the lysosomal inhibitor E64, prevented loss of RAR
and RXR
proteins after exposure of keratinocytes to either UV radiation or
cycloheximide. Soluble extracts from nonirradiated or UV-irradiated
keratinocytes possessed similar levels of proteasome activity that
degraded RAR
and RXR
proteins in vitro.
Furthermore, RAR
and RXR
were polyubiquitinated in intact cells.
RXR
was found to contain two proline, glutamate/aspartate, serine,
and threonine (PEST) motifs, which confer rapid turnover of many
short-lived regulatory proteins that are degraded by the
ubiquitin/proteasome pathway. However, the PEST motifs in RXR
did
not function to regulate its stability, because deletion of the PEST
motifs individually or together did not alter ubiquitination or
proteasome-mediated degradation of RXR
. These results demonstrate
that loss of RAR
and RXR
proteins after UV irradiation results
from degradation via the ubiquitin/proteasome pathway. Taken together,
the data here indicate that ubiquitin/proteasome-mediated breakdown is
an important mechanism regulating the levels of nuclear retinoid
receptors.
This article has been cited by other articles:
![]() |
N. G. Thaker, F. Zhang, P. R. McDonald, T. Y. Shun, M. D. Lewen, I. F. Pollack, and J. S. Lazo Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening Mol. Pharmacol., December 1, 2009; 76(6): 1246 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tateishi, R. Sonoo, Y.-i. Sekiya, N. Sunahara, M. Kawano, M. Wayama, R. Hirota, Y.-i. Kawabe, A. Murayama, S. Kato, et al. Turning Off Estrogen Receptor {beta}-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis Mol. Cell. Biol., November 1, 2006; 26(21): 7966 - 7976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D.-C. Arce, U. Soto, J. van Riggelen, E. Schwarz, H. z. Hausen, and F. Rosl Ectopic Expression of Nonliganded Retinoic Acid Receptor {beta} Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells J. Biol. Chem., October 29, 2004; 279(44): 45408 - 45416. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Moraitis and V. Giguere The Co-repressor Hairless Protects ROR{alpha} Orphan Nuclear Receptor from Proteasome-mediated Degradation J. Biol. Chem., December 26, 2003; 278(52): 52511 - 52518. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villalobo, C. Moch, G. Fryd-Versavel, A. Fleury-Aubusson, and L. Morin Cysteine Proteases and Cell Differentiation: Excystment of the Ciliated Protist Sterkiella histriomuscorum Eukaryot. Cell, December 1, 2003; 2(6): 1234 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Woodham, L. Birch, and G. S. Prins Neonatal Estrogen Down-Regulates Prostatic Androgen Receptor through a Proteosome-Mediated Protein Degradation Pathway Endocrinology, November 1, 2003; 144(11): 4841 - 4850. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chauchereau, L. Amazit, M. Quesne, A. Guiochon-Mantel, and E. Milgrom Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1 J. Biol. Chem., March 28, 2003; 278(14): 12335 - 12343. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes Mol. Cell. Biol., March 15, 2003; 23(6): 1843 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Fung, W. Y. Siu, C. H. Yam, A. Lau, and R. Y. C. Poon Cyclin F Is Degraded during G2-M by Mechanisms Fundamentally Different from Other Cyclins J. Biol. Chem., September 13, 2002; 277(38): 35140 - 35149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boskovic, D. Desai, and R. M. Niles Regulation of Retinoic Acid Receptor alpha by Protein Kinase C in B16 Mouse Melanoma Cells J. Biol. Chem., July 12, 2002; 277(29): 26113 - 26119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prufer, C. Schroder, K. Hegyi, and J. Barsony Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of Calcitriol Mol. Endocrinol., May 1, 2002; 16(5): 961 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Osburn, G. Shao, H. M. Seidel, and I. G. Schulman Ligand-Dependent Degradation of Retinoid X Receptors Does Not Require Transcriptional Activity or Coactivator Interactions Mol. Cell. Biol., August 1, 2001; 21(15): 4909 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shin, F. R. Khuri, B. Murphy, A. S. Garden, G. Clayman, M. Francisco, D. Liu, B. S. Glisson, L. Ginsberg, V. Papadimitrakopoulou, et al. Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial J. Clin. Oncol., June 15, 2001; 19(12): 3010 - 3017. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-C. Xu, W. Y. L. Wong, L. Goldberg, S. C. Baer, J. E. Wolf, W. M. Ramsdell, D. S. Alberts, S. M. Lippman, and R. Lotan Progressive Decreases in Nuclear Retinoid Receptors during Skin Squamous Carcinogenesis Cancer Res., June 1, 2001; 61(11): 4306 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lehmann, C. Paul, and H. Törmä Retinoid Receptor Expression and Its Correlation to Retinoid Sensitivity in Non-M3 Acute Myeloid Leukemia Blast Cells Clin. Cancer Res., February 1, 2001; 7(2): 367 - 373. [Abstract] [Full Text] |
||||
![]() |
G. M. Clayton, S. Y. Peak-Chew, R. M. Evans, and J. W. R. Schwabe The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation PNAS, February 1, 2001; (2001) 41611298. [Abstract] [Full Text] |
||||
![]() |
G. M. Clayton, S. Y. Peak-Chew, R. M. Evans, and J. W. R. Schwabe The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation PNAS, February 13, 2001; 98(4): 1549 - 1554. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |